TRAJECTORY ANALYSIS OF HEALTH CARE COSTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH HIGH DOSES OF DULOXETINE

被引：0
|
作者：
Cui, Z. [1 ]
Faries, D. [1 ]
Zhao, Y. [1 ]
Niu, L. [1 ]
Novick, D. [1 ]
Liu, X. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.1055
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A191 / A191
页数：1
相关论文
共 50 条
  • [21] DIFFERENCES IN HEALTH CARE USES AFTER TREATMENT OF DULOXETINE VERSUS OTHER ANTIDEPRESSANTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN VETERANS AFFAIRS HEALTH CARE NETWORK
    Shi, L.
    Liu, J.
    Zhao, Y.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A355 - A356
  • [22] Major depressive disorder, somatic pain, and health care costs in an urban primary care practice
    Gameroff, Marc J.
    Olfson, Mark
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1232 - 1239
  • [23] Analysis of Depressive Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
    Kornstein, Susan G.
    Fava, Maurizio
    Jiang, Qin
    Tourian, Karen A.
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (03) : 21 - 35
  • [24] Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
    Huang, Jia
    Wang, Yun
    Chen, Jun
    Zhang, Yanlei
    Yuan, Zheng
    Yue, Li
    Maria Haro, Josep
    Victoria Moneta, Maria
    Novick, Diego
    Fang, Yiru
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2473 - 2484
  • [25] Remission rates during treatment with duloxetine in patients with major depressive disorder
    Lu, Y
    Tran, P
    Detke, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S214 - S214
  • [26] Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder
    Brecht, Stephan
    Kajdasz, Daniel
    Ball, Susan
    Thase, Michael E.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (06) : 317 - 324
  • [27] Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder
    Fava, Maurizio
    Wiltse, Curtis
    Walker, Daniel
    Brecht, Stephan
    Chen, Andrew
    Perahia, David
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 113 (03) : 263 - 271
  • [28] Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder
    Liu, Xianchen
    Tepper, Ping G.
    Able, Stephen L.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (03) : 173 - 180
  • [29] Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder
    Shibata, Risa Yokokawa
    Kubota, Ryuji
    Uenaka, Kazunori
    Kaibara, Atsunori
    Wajima, Toshihiro
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2023, 51
  • [30] A comparison of initial duloxetine dosing strategies in patients with major depressive disorder
    Whitrayer, Virgil G.
    Dunner, David L.
    Kornstein, Susan G.
    Meyers, Adam L.
    Mallinckrodt, Craig H.
    Wohlreich, Madelaine M.
    Gonzales, Jill S.
    Greist, John H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (12) : 1921 - 1930
12345